Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Commitments and Contingencies (Details Textual)

v3.21.2
Note 11 - Commitments and Contingencies (Details Textual) - USD ($)
1 Months Ended 3 Months Ended
Apr. 21, 2021
Mar. 16, 2021
Nov. 27, 2019
Apr. 09, 2018
Nov. 02, 2017
Mar. 03, 2017
Dec. 31, 2019
Nov. 30, 2018
Aug. 31, 2018
Nov. 30, 2017
Jun. 30, 2016
Jun. 30, 2021
Dec. 31, 2020
Stock Issued During Period, Shares, New Issues (in shares)             2,100,000            
Stockholders' Equity Attributable to Parent, Ending Balance                       $ 5,704,870 $ 1,315,604
Market Capitalization, Fair Value                       $ 55,200,000  
Common Stock [Member]                          
Stock Issued During Period, Shares, New Issues (in shares)                       0  
Former Chief Executive Officer and President [Member]                          
Common Stock Shares Provided by Agreement (in shares)                 1,175,000        
Common Stock Shares Provided by Agreement, Escrow Period (Month)                 18 months        
Former Chief Executive Officer and President [Member] | Common Stock [Member]                          
Stock Issued During Period, Shares, New Issues (in shares)               925,000          
Stock Issued During Period, Shares, New Issues Placed in Escrow (in shares)               250,000          
Former Chief Executive Officer and President [Member] | MT [Member] | Common Stock [Member] | Dr. Michael Goldberg [Member]                          
Ownership Percentage                 5.00%        
CRG [Member]                          
Draws on Letter of Credit       $ 7,100,000                  
CRG Loan Agreement, Texas Case [Member] | Judicial Ruling [Member]                          
Loss Contingency, Damages Awarded, Value, Additional Amount           $ 7,000,000.0              
Loss Contingency, Damages Awarded, Value, Amount not Taken into Consideration                     $ 4,100,000    
Ohio Court of Common Pleas [Member]                          
Litigation Settlement, Amount Awarded from Other Party     $ 4,300,000                    
Litigation Settlement, Reversal of Amount Awarded from Other Party   $ 4,300,000                      
Platinum-Montaur Life Sciences LLC Litigation [Member]                          
Loss Contingency, Damages Sought, Value                   $ 1,900,000      
Platinum-Montaur Life Sciences LLC Litigation [Member] | Pending Litigation [Member]                          
Loss Contingency, Damages Sought, Value         $ 1,900,000                
New York Litigation Involving Former CEO and President [Member] | Judicial Ruling [Member]                          
Litigation Settlement, Amount Can Be Awarded to Other Party for Indemnification for Attorneys’ Fees $ 14,955                        
Litigation Settlement, Amount Can Be Advanced to Other Party for Attorneys’ Fees Subject to Repayment $ 1,237.50                        
CRG [Member] | Term Loan Agreement [Member] | CRG Loan Agreement, Texas Case [Member] | Judicial Ruling [Member]                          
Repayments of Debt           59,000,000.0              
CRG [Member] | Term Loan Agreement [Member] | Maximum [Member]                          
Debt Instrument, Agreed-upon Final Payoff Amount           $ 66,000,000.0